• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Device Problems Fracture (1260); Loosening of Implant Not Related to Bone-Ingrowth (4002); Migration (4003)
Patient Problems Unspecified Infection (1930); Inflammation (1932); Pain (1994); Swelling/ Edema (4577)
Event Type  Injury  
Manufacturer Narrative
Literature citation: metikala et al.Adverse events related to polyvinyl alcohol hydrogel hemiarthroplasty of 1st metatarsal: an analysis of reports to the united states food and drug administration.Foot & ankle orthopaedics.2020; 5:4.The device was not returned for evaluation.
 
Event Description
It was reported in a literature article by metikala el al.Titled adverse events related to polyvinyl alcohol hydrogel hemiarthroplasty of 1st metatarsal: an analysis of reports to the united states food and drug administration did a retrospective review of maude database between july 2016 and october 2019 using the assigned product code: pnw for the polyvinyl alcohol hydrogel implant.A total of 49 events have been reported to this voluntary database over the past 3 years while over 22,000 cartiva devices have been implanted.Implant subsidence was the most common with 16 reported instances.Fragmentation of the device was observed in nine and four reports were related to infection in which two were deep infections needing antibiotic spacers.Bone erosion managed by grafting was documented in three reports and foreign body reaction was noted in one.Persistent pain and swelling were common presentations.Thirty-five of 49 reported events required additional operative procedures performed at a mean interval of 4.75 months following the index procedure while four more were awaiting further surgery.Conversion to fusion was the most common procedure, featured in 10 reports.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer (Section G)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer Contact
matthew parrish
1023 cherry rd
memphis, TN 38117
MDR Report Key11279785
MDR Text Key231133383
Report Number3009351194-2021-00088
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/06/2021
Initial Date FDA Received02/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-